These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 35111046

  • 1. Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
    Lee SW, Lyu YR, Kim SY, Yang WK, Kim SH, Kim KM, Chae SW, Kang W, Jung IC, Park YC.
    Front Pharmacol; 2021; 12():761575. PubMed ID: 35111046
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial.
    Lyu YR, Yang WK, Park SJ, Kim SH, Kang WC, Jung IC, Park YC.
    BMJ Open; 2018 May 14; 8(5):e019897. PubMed ID: 29764875
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of HL301 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitis: a phase 2, randomized, double-blind, placebo-controlled, multicenter study.
    Park MJ, Rhee CK, Kim YH, Kim DJ, Kim DG, Lee SY, Kim JY.
    Curr Med Res Opin; 2017 May 14; 33(5):919-925. PubMed ID: 28277874
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial.
    Kemmerich B.
    Arzneimittelforschung; 2007 May 14; 57(9):607-15. PubMed ID: 17966760
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial.
    Kemmerich B, Eberhardt R, Stammer H.
    Arzneimittelforschung; 2006 May 14; 56(9):652-60. PubMed ID: 17063641
    [Abstract] [Full Text] [Related]

  • 6. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM, Beier J, Candler H, Wittig T.
    Int J Chron Obstruct Pulmon Dis; 2016 May 14; 11():2877-2884. PubMed ID: 27920515
    [Abstract] [Full Text] [Related]

  • 7. HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study.
    Yoon SW, Park MJ, Rhee CK, Park JH, Lee SY, Kim DJ, Kim DG, Kim JY.
    Korean J Intern Med; 2020 Jan 14; 35(1):133-141. PubMed ID: 30962409
    [Abstract] [Full Text] [Related]

  • 8. Effect of Plantago major on cough severity in acute bronchitis: A double-blind randomized clinical trial.
    Naderi A, Mozaffarpur SA, Shirafkan H, Bayani M, Memariani Z.
    Caspian J Intern Med; 2024 Jan 14; 15(4):651-658. PubMed ID: 39359439
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Ojeok-San Plus Saengmaek-San for Gastroesophageal Reflux-Induced Chronic Cough: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial.
    Lyu YR, Kim KI, Yang C, Jung SY, Kwon OJ, Jung HJ, Lee JH, Lee BJ.
    Front Pharmacol; 2022 Jan 14; 13():787860. PubMed ID: 35300295
    [Abstract] [Full Text] [Related]

  • 10. HL301 versus Umckamin in the treatment of acute bronchitis: a phase III, randomized, controlled, double-blind, multicenter study.
    Kim WY, Park MJ, Rhee CK, Lee SY, Kim DJ, Kim DG, Choi CM, Kim DK, Kim YH, Yoon HJ, Kim JY.
    Curr Med Res Opin; 2020 Mar 14; 36(3):503-508. PubMed ID: 31855086
    [Abstract] [Full Text] [Related]

  • 11. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
    Grossman R, Mukherjee J, Vaughan D, Eastwood C, Cook R, LaForge J, Lampron N.
    Chest; 1998 Jan 14; 113(1):131-41. PubMed ID: 9440580
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H, de Mey C, Carls C, Ryś A, Geib A, Wittig T.
    Arzneimittelforschung; 2000 Aug 14; 50(8):700-11. PubMed ID: 10994153
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial.
    Han KI, Kim TH, Ra SW, Yoon HK, Kim DK, Rhee CK, Park JW, Hwang YI, Park HY, Kim YH, Park YB, Shin KC, Lim SY, Yoo KH.
    Curr Med Res Opin; 2024 Jul 14; 40(7):1235-1243. PubMed ID: 38889376
    [Abstract] [Full Text] [Related]

  • 14. The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial.
    Ra SW, Kim SY, Lim YY, Park SJ, Rhee CK, Kim DK, Park YB, Lee CY, Yoon HK, Park JW, Yoo KH.
    J Thorac Dis; 2021 Jan 14; 13(1):1-9. PubMed ID: 33569179
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of Tanreqing oral liquid in treatment of acute bronchitis: study protocol for a randomized controlled trial.
    Cheng G, She B, Mao B, Jiang H.
    Trials; 2022 May 07; 23(1):373. PubMed ID: 35526026
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides.
    Matthys H, Lizogub VG, Malek FA, Kieser M.
    Curr Med Res Opin; 2010 Jun 07; 26(6):1413-22. PubMed ID: 20387996
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, randomized, double-blind, phase III clinical trial.
    Lee YS, Lim SY, Min KH, Kim DJ, Yoo KH, Kim TB, Kim HR, Shim JJ.
    Korean J Intern Med; 2022 Nov 07; 37(6):1195-1204. PubMed ID: 36153858
    [Abstract] [Full Text] [Related]

  • 18. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F, Schaberg T, Centanni S, Del Vecchio A, Rosignoli MT, Dionisio P.
    Pulm Pharmacol Ther; 2013 Oct 07; 26(5):609-16. PubMed ID: 23538168
    [Abstract] [Full Text] [Related]

  • 19. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study.
    Matthys H, Heger M.
    Curr Med Res Opin; 2007 Feb 07; 23(2):323-31. PubMed ID: 17288687
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots.
    Kamin W, Maydannik V, Malek FA, Kieser M.
    Int J Clin Pharmacol Ther; 2010 Mar 07; 48(3):184-91. PubMed ID: 20197012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.